pentoxifylline has been researched along with Cognitive Dysfunction in 1 studies
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Due to the inflammatory factors in the pathophysiology of schizophrenia, Pentoxifylline, as anti-inflammatory medication, seems to improve the symptoms of schizophrenia." | 9.69 | Pentoxifylline as adjunctive therapy in cognitive deficits and symptoms of schizophrenia: A randomized double-blind placebo-controlled clinical trial. ( Farid Hosseini, F; Fayyazi-Bordbar, M; Jamali, J; Mohammadpour, A; Sinichi, F; Sinichi, M, 2023) |
| "Due to the inflammatory factors in the pathophysiology of schizophrenia, Pentoxifylline, as anti-inflammatory medication, seems to improve the symptoms of schizophrenia." | 5.69 | Pentoxifylline as adjunctive therapy in cognitive deficits and symptoms of schizophrenia: A randomized double-blind placebo-controlled clinical trial. ( Farid Hosseini, F; Fayyazi-Bordbar, M; Jamali, J; Mohammadpour, A; Sinichi, F; Sinichi, M, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sinichi, F | 1 |
| Farid Hosseini, F | 1 |
| Fayyazi-Bordbar, M | 1 |
| Sinichi, M | 1 |
| Jamali, J | 1 |
| Mohammadpour, A | 1 |
1 trial available for pentoxifylline and Cognitive Dysfunction
| Article | Year |
|---|---|
Pentoxifylline as adjunctive therapy in cognitive deficits and symptoms of schizophrenia: A randomized double-blind placebo-controlled clinical trial.
Topics: Antipsychotic Agents; Cognition; Cognitive Dysfunction; Double-Blind Method; Drug Therapy, Combinati | 2023 |